What initial evaluation and management are recommended for a patient with fatigue, intermittent dizziness without syncope, increased home stress, and mild leukocytosis with an elevated absolute lymphocyte count?

Initial Evaluation and Management

This patient requires a focused workup to exclude chronic lymphocytic leukemia (CLL) or monoclonal B-cell lymphocytosis (MBL), followed by systematic evaluation of treatable causes of fatigue, rather than immediate treatment. The absolute lymphocyte count of 4001/μL (4.0 × 10⁹/L) sits at the diagnostic threshold for CLL and warrants immunophenotyping to determine if a monoclonal B-cell population exists 1, 2.

Step 1: Rule Out Lymphoproliferative Disorder

The lymphocyte count of 4001/μL is precisely at the CLL diagnostic threshold (≥4000/μL per established guidelines) 1, 2. Order flow cytometry immunophenotyping of peripheral blood immediately to assess for:

• CD19, CD20, CD23, and CD5 co-expression (characteristic of CLL)
• Surface immunoglobulin light chain restriction (kappa or lambda monoclonality)
• Low-density surface immunoglobulin expression 2

Key distinction: Even if monoclonal B-cells are present, this patient does NOT require treatment unless they meet criteria for "active disease" 1, 3. The mild WBC elevation (11.4) and fatigue alone are insufficient treatment indications.

CLL Treatment Criteria (Must Have ≥1 of the Following):

• Progressive marrow failure (anemia/thrombocytopenia developing or worsening)
• Massive splenomegaly (≥6 cm below left costal margin) or progressive/symptomatic
• Massive lymphadenopathy (≥10 cm longest diameter) or progressive/symptomatic
• Progressive lymphocytosis (>50% increase over 2 months OR lymphocyte doubling time <6 months)
• Significant fatigue defined as ECOG PS ≥2 (inability to work or perform usual activities) 1, 3

Critical caveat: The fatigue described does not clearly meet the "significant fatigue" threshold requiring CLL treatment. If the patient can still work and perform usual activities, this is NOT a treatment indication even if CLL is confirmed 1.

Step 2: Comprehensive Fatigue Assessment

If immunophenotyping is negative or shows low-level monoclonality without treatment indications, proceed with systematic fatigue evaluation 4:

Mandatory Laboratory Testing:

• Complete blood count with differential (already done - review for anemia, thrombocytopenia)
• Comprehensive metabolic panel (electrolytes, hepatic/renal function)
• TSH (thyroid dysfunction is common and treatable)
• Consider ferritin, vitamin B12, folate if anemia present 4

Focused History Elements:

• Fatigue pattern: Onset, duration, change over time, alleviating factors
• Functional impact: Can they work? Perform usual activities? (determines if ECOG PS ≥2)
• Constitutional symptoms: Unintentional weight loss ≥10% in 6 months, fevers >38°C for ≥2 weeks, night sweats >1 month 1
• Medication review: Sleep aids, pain medications, antiemetics that may contribute
• Psychosocial stressors: The "increased home situational stress" may be primary driver 4

Physical Examination Priorities:

• Lymph node examination (cervical, axillary, inguinal - assess for masses ≥10 cm)
• Spleen palpation (assess if ≥6 cm below left costal margin)
• Hepatomegaly assessment
• Signs of anemia, infection, or other systemic illness 1, 3

Step 3: Address Dizziness

The intermittent dizziness without syncope requires:

• Orthostatic vital signs (rule out volume depletion, autonomic dysfunction)
• Review medications that may cause dizziness
• Assess for anemia (hemoglobin already in CBC)
• Consider cardiac evaluation if orthostatic hypotension or concerning features present

Important: Dizziness is NOT a criterion for CLL treatment and is likely multifactorial (stress, possible dehydration, medication effect) 1.

Step 4: Management Algorithm

If Immunophenotyping Shows Monoclonal CLL/MBL:

• No treatment indicated unless active disease criteria met 1, 3
• Watch-and-wait strategy with clinical examination and CBC every 3-12 months 3
• Patient education about CLL natural history and when treatment becomes necessary
• Address modifiable fatigue contributors (see below)

If Immunophenotyping Negative:

• Treat identified causes: thyroid dysfunction, anemia, sleep disturbance, depression/anxiety
• Address psychosocial stressors: Consider referral for stress management, counseling for home situational stress 4
• Lifestyle modifications: Maintain physical activity, sleep hygiene, nutritional optimization 4
• Re-evaluate in 4-6 weeks to assess response to interventions

Common Pitfalls to Avoid

1. Do not treat lymphocytosis alone: Absolute lymphocyte count is NOT a sole treatment indication for CLL 1
2. Do not assume malignancy: Mild lymphocytosis has many reactive causes (infections, stress, medications) 5, 6
3. Do not overlook treatable causes: Thyroid dysfunction, anemia, sleep disorders, and psychological distress are common and reversible 4
4. Do not delay immunophenotyping: This is the definitive test to establish or exclude a lymphoproliferative disorder at this threshold 2, 7

Bottom line: Order flow cytometry now, examine for lymphadenopathy/splenomegaly, obtain TSH and metabolic panel, and address the home stress as a likely major contributor to symptoms. Treatment is only indicated if active CLL criteria are met, which currently they are not.